Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tdap

PreclinicalBiologic

Tdap is one of 55 biologic programs targeting HIV infection. It is currently in Preclinical.

2

Indications

14

Total Trials

0

Active Trials

54

Competitors

Pipeline

Status by Indication[3][1]

Indication

HIV InfectionActive, not recruiting

Immune FunctionCompleted

HIV InfectionPreclinical

Active, not recruiting

Immune FunctionPreclinical

Completed

Competition

Competitive Landscape

123 competitors in HIV Infection

#DrugCompanyPhaseTrials

Jakafi

Estrace

Epidiolex

Jazz Pharmaceuticals

Depakote

Tegretol

Niacor

Soriatane

Rifadin

Ninlaro

Tybost

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immunogenicity3 trials

Safety, Tolerability and Immunogenicity of a Third Dose of One of Four Different Formulations of rMenB + MenACWY Combination Vaccine in Adolescents Who Previously Received the Same Study Vaccines

Completed· Novartis logo

Novartis·Phase 2·NCT01367158·440 enrolled

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Completed· Pfizer logo

Pfizer·Phase 1·NCT02955160·66 enrolled

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Completed· Sanofi logo

Sanofi·Phase 3·NCT00467519·1,045 enrolled

Vaccine2 trials

A Trial To Evaluate A Multivalent Pneumococcal Conjugate Vaccine In Healthy Adults 50-85 Years Of Age

Completed· Pfizer logo

Pfizer·Phase 2·NCT03313050·511 enrolled

Homeopathic Vaccine Trial

Unknown status·MMcMaster University·Phase 4·NCT02825368

Pregnant Women2 trials

TDAP Safety in Pregnant Women

Completed·VVanderbilt University··NCT02209623·375 enrolled

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Completed· Pfizer logo

Pfizer·Phase 2·NCT04071158·713 enrolled

Immunization2 trials

Pertussis Maternal Immunization Study

Completed·SScott Halperin·Phase 2/3·NCT00553228·320 enrolled

Maternal Tdap Immunization in Guatemala

Completed·EEmory University·Phase 2·NCT02301702·286 enrolled

Vaccine Response1 trial

A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 1·NCT05827874·32 enrolled

4 more indications

HIV infection1 trial

Pertussis Immunization During Pregnancy & HIV Infection

Completed·—··NCT03519373·135 enrolled

Immune Function1 trial

Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults

Completed·VVA Office of Research and Development·N/A·NCT02261961·59 enrolled

Satisfaction1 trial

Pharmacists as Immunizers to Improve Coverage and Provider/Recipient Satisfaction

Completed·CCanadian Immunization Research Network·Phase 4·NCT02868970·2,404 enrolled

Tetanus, Diphtheria and Acellular Pertussis Vaccination1 trial

A Clinical Study of the Safety and Antibody Responses of Plasma Donors Vaccinated With a Licensed Tdap Vaccine for a Hyperimmunization Program

Completed·AABO Holdings, Inc.·Phase 2·NCT05662852·107 enrolled

Sources

References

[1]
ClinicalTrials.gov — 14 trial records for Tdap. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tdap compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tdap. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: Pfizer

Related News